Discontinued — last reported Q1 '18
Halliburton Allowance for Doubtful Accounts Receivable (Current) decreased by 2.9% to $782.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.6%, from $755.00M to $782.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows relatively stable performance with a -0.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $774.00M | $765.00M | $754.00M | $751.00M | $746.00M | $741.00M | $731.00M | $720.00M | $723.00M | $718.00M | $742.00M | $743.00M | $752.00M | $756.00M | $754.00M | $755.00M | $755.00M | $757.00M | $805.00M | $782.00M |
| QoQ Change | — | -1.2% | -1.4% | -0.4% | -0.7% | -0.7% | -1.3% | -1.5% | +0.4% | -0.7% | +3.3% | +0.1% | +1.2% | +0.5% | -0.3% | +0.1% | +0.0% | +0.3% | +6.3% | -2.9% |
| YoY Change | — | — | — | — | -3.6% | -3.1% | -3.1% | -4.1% | -3.1% | -3.1% | +1.5% | +3.2% | +4.0% | +5.3% | +1.6% | +1.6% | +0.4% | +0.1% | +6.8% | +3.6% |